Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

当地时间1月15日，美国人工智能编程公司Replit宣布推出vibe ...